ECSP951610A - TACHYCININ ANTAGONISTS - Google Patents

TACHYCININ ANTAGONISTS

Info

Publication number
ECSP951610A
ECSP951610A ECSP951610A ECSP951610A EC SP951610 A ECSP951610 A EC SP951610A EC SP951610 A ECSP951610 A EC SP951610A EC SP951610 A ECSP951610 A EC SP951610A
Authority
EC
Ecuador
Prior art keywords
phenyl
sulfur
tachycinin
antagonists
indole
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Soo Young Ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951610 priority Critical patent/ECSP951610A/en
Publication of ECSP951610A publication Critical patent/ECSP951610A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Se proporciona compuestos de fórmula I (gráfico), en la que R1 es fenil mono o disustituido, n es cero ó 1, X1 es oxígeno, azufre o =NCN, X2 y X3 son cada uno independientemente oxígeno o azufre, R2 es hidrógeno o metilo, R3 es fenilo, fenilo sustituido con halo, 2-naftilo, IH-indol-3-ilo o 1-metil-indol -3-ilo, Z es N(CH3) -o -CH2-, R4 es fenilo, 3,65 bis (trifluorometil) fenilo o piridilo, y R5 es hidrógeno, fenilo, 3,5 -bis (trifluorometil)fenilo o piridilo, por lo que , cuando X3 es azufre, Z es -N (CH3) -, y una sakl de adición de ácido del mismo que tiene actividad antagonista para taquicinina, y son útiles como sustancias farmacéuticamente, por ejemplo, para el tratamiento del dolor.Compounds of formula I (graph) are provided, wherein R1 is mono or disubstituted phenyl, n is zero or 1, X1 is oxygen, sulfur or = NCN, X2 and X3 are each independently oxygen or sulfur, R2 is hydrogen or methyl, R3 is phenyl, halo-substituted phenyl, 2-naphthyl, IH-indole-3-yl or 1-methyl-indole -3-yl, Z is N (CH3) -o -CH2-, R4 is phenyl, 3 , 65 bis (trifluoromethyl) phenyl or pyridyl, and R5 is hydrogen, phenyl, 3,5-bis (trifluoromethyl) phenyl or pyridyl, whereby, when X3 is sulfur, Z is -N (CH3) -, and a sakl of acid addition thereof having antagonist activity for tachykinin, and are useful as substances pharmaceutically, for example for the treatment of pain.

ECSP951610 1995-12-12 1995-12-12 TACHYCININ ANTAGONISTS ECSP951610A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951610 ECSP951610A (en) 1995-12-12 1995-12-12 TACHYCININ ANTAGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951610 ECSP951610A (en) 1995-12-12 1995-12-12 TACHYCININ ANTAGONISTS

Publications (1)

Publication Number Publication Date
ECSP951610A true ECSP951610A (en) 1997-06-27

Family

ID=42042252

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951610 ECSP951610A (en) 1995-12-12 1995-12-12 TACHYCININ ANTAGONISTS

Country Status (1)

Country Link
EC (1) ECSP951610A (en)

Similar Documents

Publication Publication Date Title
MX9803753A (en) CYCLIC AND HETEROCYCLIC N-SUBSTITUTED 'alpha'-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS.
DK51986D0 (en) HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE AS INSECTICIDE AGENTS
CL2003002756A1 (en) COMPOUNDS DERIVED FROM (1-CARBAMOIL-1,1-DEFENILMETIL) -1- [SUBSTITUTED) RENT] PURROLIDINES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF THE IRRITABLE INTESTINE SYNDROME OR INCONTINENCE.
ES2155067T3 (en) SUBSTITUTED PHENYLIMIDAZOLIDINS, THEIR APPLICATION AS MEDICINES AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2191048T3 (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM.
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
SE9702564D0 (en) New compounds
DE69901717D1 (en) PHOSPHOHALOHYDRINE, METHOD FOR THE PRODUCTION AND USE THEREOF
IL71324A0 (en) N-phenyl-n'-cycloalkylalkanoyl-piperazines,their production and pharmaceutical compositions containing them
DK0409435T3 (en) Heteroberl piperazines as antipsychotics
ATE153022T1 (en) 3',5'-DITERTBUTYL-4'-HYDROXYFLAVONES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION HAVING ANTIOXIDATION AND ANTIVASOCONSTRICTION ACTIVITY
ES2177581T3 (en) USE OF PIPERIDINE COMPOUNDS IN THE TREATMENT OF SCHIZOPHRENIA.
DE69525354D1 (en) A NEW MEDICAL USE OF A 5HT 3 ANTAGONIST
DE69507293D1 (en) BENZAMIDE DERIVATIVES AS VASOPRESSINE ANTAGONISTS
ES2140381T3 (en) NEW 4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONAS DISSTITUTED IN 2.9.
DE69229339D1 (en) CRYSTALLINE TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PRODUCTION AND USE
NO961000L (en) Piperidine derivatives, process for their preparation and drug and preparation containing them
SE9702563D0 (en) Compounds
ES2134732B1 (en) "STABILIZING MIXTURES".
DE60014343D1 (en) N- (2-PHENYL-4-AMINO-BUTYL) -1-NAPHTHAMIDE AS NEUROKININ-1 RECEPTOR ANTAGONISTS
SE8500107D0 (en) NEW 8ALFA-ACYLAMINOERGOLINE
ECSP951610A (en) TACHYCININ ANTAGONISTS
DE69837334D1 (en) Heterocyclic compounds, their method of preparation and pharmaceutical compositions containing them
ATE144510T1 (en) N-(ISOCHINOLEIN-5-YL)-SULFONYL AZAZYKLOALKANES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
BG105794A (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions contaning the same